Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care

Bruton’s tyrosine kinase (BTK) regulates critical signal transduction pathways involved in the pathobiology of rheumatoid arthritis (RA) and other autoimmune disorders. BMS-986142 is a potent and highly selective reversible small molecule inhibitor of BTK currently being investigated in clinical tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillooly, Kathleen M., Pulicicchio, Claudine, Pattoli, Mark A., Cheng, Lihong, Skala, Stacey, Heimrich, Elizabeth M., McIntyre, Kim W., Taylor, Tracy L., Kukral, Daniel W., Dudhgaonkar, Shailesh, Nagar, Jignesh, Banas, Dana, Watterson, Scott H., Tino, Joseph A., Fura, Aberra, Burke, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524405/
https://www.ncbi.nlm.nih.gov/pubmed/28742141
http://dx.doi.org/10.1371/journal.pone.0181782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524405/
https://www.ncbi.nlm.nih.gov/pubmed/28742141
http://dx.doi.org/10.1371/journal.pone.0181782

Ejemplares similares